Thyroid-Stimulation Hormone - Receptor Antibodies as a Predictor of Thyrosuppressive Drug Therapy Outcome in Graves’ Disease Patients

Medicinski Pregled - Serbia
doi 10.2298/mpns1410305a
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

National Library of Serbia

Related search

Thyroid‐stimulating Hormone Receptor Antibodies During Follow‐up as Remission Markers in Childhood‐onset Graves' Disease Treated With Antithyroid Drugs

Kaohsiung Journal of Medical Sciences
Medicine
2020English

Recent Outcome of Graves' Disease Patients With Papillary Thyroid Cancer

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2007English

A Water-Soluble Fragment of the Thyroid-Stimulating Hormone Receptor Which Binds Both Thyroid-Stimulating Hormone and Thyroid-Stimulating Hormone Receptor Antibodies

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
1984English

The Nature of the Circulating Thyroid Hormone in Graves' Disease 1

Journal of Clinical Investigation
Medicine
1951English

Thyroid-Stimulating Antibodies in Sera From Patients With Graves' Disease Are Heterogeneous in Epitope Recognition

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1995English

Graves’ Disease Coexisting With Resistance to Thyroid Hormone: A Rare Case

Clinical Case Reports
Medicine
2017English

Studies on Multiple Thyroid Cell Membrane-Directed Antibodies in Graves' Disease.

Journal of Clinical Investigation
Medicine
1985English

Thyroid Hormone Transport in the Serum of Patients With Thyrotoxic Graves' Disease Before and After Treatment

Journal of Clinical Investigation
Medicine
1968English

Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients With Atrophic Thyroid After Radioiodine Treatment for Graves' Disease

Thyroid
MedicineEndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy